Biomarkers Market Research Reports & Industry Analysis
Biomarkers are measurable indicators, such as molecules or genetic mutations, that provide information about a biological process, condition, or disease in the body. As healthcare evolves, it's important to grasp the impact and unique dynamics of this industry. At MarketResearch.com, we understand the need for reliable data on this sector. Our biomarkers market research reports provide a comprehensive and informative analysis, empowering you to navigate this dynamic industry with greater confidence.
Biomarkers Industry Insights
- Our research covers diverse markets so you can quickly and easily find research on segments big and small.
- Through our platform, you can access essential data to drive strategic decisions, from biomarkers market sizing and growth projections to key drivers and challenges.
- Use our research to better understand products under development, market trends, competitor analysis, and leading players.
Harnessing MarketResearch.com's Expertise
For more than twenty years, MarketResearch.com has been a leader in the field of market research, serving a diverse clientele that includes top investment banks, management consulting firms, and multinational corporations. We are known for providing reliable insights and offer a centralized platform with access to reports from numerous firms. In addition, our research specialists are available to provide expert guidance and support every step of the way.
Biomarkers Industry Research & Market Reports
-
Biomarkers Global Market Briefing 2022
... to grow from $47.69 billion in 2021 to $179.22 billion in 2031 at a CAGR of 14.16%. Biomarkers Global Market Briefing 2022 provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Global Biomarker Testing Services Market Size study & Forecast, by Product (Biomarker Assay Development, Flow Cytometry and Others) by End User (Pharmaceutical and biotechnology companies, Research Institutes and CRO) and Regional Analysis, 2022-2029
... Testing Services Market is valued at approximately USD 759.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2022-2029. Biomarker testing services give ... Read More
-
Global Personalized Medicine Biomarkers Market Size study & Forecast, by Indication (Oncology, Diabetes, Autoimmune Diseases, Cardiology, Others) by Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring) and Regional Analysis, 2022-2029
... valued at approximately USD 11.76 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 15.51% over the forecast period 2022-2029. Personalized medicine biomarkers are essential tools that are ... Read More
-
South America Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Autosamplers, Micropumps, UV Detectors, UPLC, Variable-Length Fluorescence Detectors, and Others], Assays For Lipid Metabolism, Lipid Flux Using Heavy Isotope-Labeled Precursors, Software & Services, and Others}, Services (Biomarker Identification, Bioinformatic Analysis & Data Interpretation, Molecular Analysis of a Broad Spectrum of Phospholipids (Lipid Fingerprinting), Analysis & Identification of Unusual Lipids, Semiquantitative & Quantitative Analysis, Lipid Flux Studies, and Others), and End User (Molecular Research, Cellular Research, Clinical Research, Tissue & Organ Research, Data Research, Organism Research, Technical Services & Prototyping, Production, and Others)
... Detectors, UPLC, Variable-Length Fluorescence Detectors, and Others], Assays For Lipid Metabolism, Lipid Flux Using Heavy Isotope-Labeled Precursors, Software & Services, and Others}, Services (Biomarker Identification, Bioinformatic Analysis & Data Interpretation, Molecular Analysis of a Broad ... Read More
-
Asia-Pacific Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Autosamplers, Micropumps, UV Detectors, UPLC, Variable-Length Fluorescence Detectors, and Others], Assays For Lipid Metabolism, Lipid Flux Using Heavy Isotope-Labeled Precursors, Software & Services, and Others}, Services [Biomarker Identification, Bioinformatic Analysis & Data Interpretation, Molecular Analysis of a Broad Spectrum of Phospholipids (Lipid Fingerprinting), Analysis & Identification of Unusual Lipids, Semiquantitative & Quantitative Analysis, Lipid Flux Studies, and Others], and End User (Molecular Research, Cellular Research, Clinical Research, Tissue & Organ Research, Data Research, Organism Research, Technical Services & Prototyping, Production, and Others)
... UPLC, Variable-Length Fluorescence Detectors, and Others], Assays For Lipid Metabolism, Lipid Flux Using Heavy Isotope-Labeled Precursors, Software & Services, and Others}, Services [Biomarker Identification, Bioinformatic Analysis & Data Interpretation, Molecular Analysis of a Broad Spectrum ... Read More
-
Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 16.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.42% during 2023-2028. Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. ... Read More
-
Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), COVID-19 Impact ... Read More
-
APAC In Situ Hybridization Market by Products (Consumables, Instruments, Software), Technology (DNA FISH, RNA FISH, PNA FISH, CISH), Application (Cancer, Immunology, Neuroscience, Cytology), End User (Hospital, Pharma, Biotech, CROs) - Forecast to 2027
... Pacific in situ hybridization market is projected to reach USD 744 million by 2027 from USD 363 million in 2022, at a CAGR of 15.4% during the forecast period. Companion diagnostic products showcase a significant ... Read More
-
Global Biomarkers Market Growth (Status and Outlook) 2023-2029
... past sales and reviews total world Biomarkers sales in 2022, providing a comprehensive analysis by region and market sector of projected Biomarkers sales for 2023 through 2029. With Biomarkers sales broken down by region, market ... Read More
-
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2023-2029
... indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.” Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical ... Read More
-
2023 Czech Republic Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... other published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
Middle East Liquid Biopsy Market - By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In-Situ Hybridization (FISH), Other Technologies); By Work Flow (Sample Preparation, Library Preparation, Sequencing, Data Analysis); By Usage (Research Use Only (RUO), Clinical); By Sample (Blood, Urine, Saliva); By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, Other Circulating Biomarkers); By Product (Tests/Services, Kits and Consumables, Instruments), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Only (RUO), Clinical); By Sample (Blood, Urine, Saliva); By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Cell-Free RNA, Exosomes and Extracellular Vesicles, Other Circulating Biomarkers); By Product (Tests/Services, Kits and Consumables, Instruments), ... Read More
-
United States Liquid Biopsy Market Revenue and Forecast to 2028-Segmentation by Biomarker Type, by Products, by Therapeutic Application, by Cancer Type, by Cities
... between 3%-6% in last five years and despite of disturbances in the year 2020 the market witnessed a positive growth, owing to the increasing number of cancer patients and liquid biopsy being on introduction stage. ... Read More
-
Global Liquid Biopsy Market – Analysis by Biomarker Type (CTCs, ctDNA, EVs, Others), Product (Assay Kits, Instruments and Devices, Services), By Indication By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)
... Executive Summary The Global Liquid Biopsy Market was valued at USD 2.2 Billion in the year 2021 backed by several initiatives to raise cancer awareness launched by governments and global health organizations over the last ... Read More
-
Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarray), Flow Cytometry, Microfluidics, Immunoassay, Biomarker, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)
... Syndromic Panel-Based Testing, and Microarray), Flow Cytometry, Microfluidics, Immunoassay, Biomarker, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User ... Read More
-
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030
... testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030. The growth in the U.S. prostate cancer testing market is ... Read More
-
Renal Biomarkers: Technologies and Global Markets
... regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and ... Read More
-
2023 Global Forecast for Cardiac Marker Testing Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
-
Healthcare Analytical Testing Services Market by Type (Biomarker Testing, Stability Testing, Raw Material Testing, Batch-release Testing, Cleaning Validation, End User (Pharmaceutical Companies, Medical Device Companies, CRO) - Global Forecast to 2027
... services market is projected to reach USD 11.1 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 11.4%. Growth in the market is driven by the rising trend of outsourcing of ... Read More
-
Microarray Market 2022-2028
... technology has a wide range of applications and found its increasing use in pharmaceutical target screening, drug discovery, basic molecular biology, biomarker identification, and others. The microarray technology can facilitate the analysis of thousands of ... Read More
-
Global Liquid Biopsy Market: Analysis By Product & Services (Kits & Reagents, Platforms & Instruments and Services), By Circulating Biomarker (Circulating Tumor Cell, CT-DNA, Extracellular Vesicles, and Others), By End-User (Hospitals & Laboratories, and Government & Academic Research Centers), By Application (Cancer, and Non Cancer) By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... & Academic Research Centers), By Application (Cancer, and Non Cancer) By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 The global liquid biopsy market in 2021 stood at US$1.28 billion, ... Read More
-
Global Cardiac Biomarkers Market - 2022-2029
... CAGR of 10.5% during the forecast period (2022-2029). Cardiac biomarkers are biological molecules released into the blood as the heart is damaged or under stress. Identifying and estimating such biomarkers help diagnose acute coronary syndrome ... Read More
-
Alzheimer’s Disease Biomarkers Market (Type of Biomarker: CSF Biomarkers, Genetic Biomarkers, and Blood Biomarkers; and Detection Technique; Molecular Diagnostics and Immunoassays) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Market – Scope of Report TMR’s report on the global alzheimer’s disease biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the ... Read More
-
Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025
... emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as significant drivers of the cTn diagnostics market. Hospitals and clinical laboratories adopt ... Read More
-
Liquid Biopsy Market by Product (Assay Kits, Instruments), Circulating Biomarkers (CTC, ctDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast), Non-Cancer), Sample Type (Blood), End User (Reference Lab, Hospitals) - Global Forecast to 2027
... liquid biopsy market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% during the forecast period. Market growth is driven by factors such as ... Read More
Research Assistance
